CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE1682.0042.65 (+2.6 %)
PREV CLOSE () 1639.35
OPEN PRICE () 1642.60
BID PRICE (QTY) 1682.00 (14)
OFFER PRICE (QTY) 1682.95 (1)
VOLUME 121536
TODAY'S LOW / HIGH ()1636.20 1708.85
52 WK LOW / HIGH ()1086.8 1870
NSE1687.2049.6 (+3.03 %)
PREV CLOSE() 1637.60
OPEN PRICE () 1646.00
BID PRICE (QTY) 1686.00 (5)
OFFER PRICE (QTY) 1686.70 (20)
VOLUME 1433074
TODAY'S LOW / HIGH() 1633.60 1709.00
52 WK LOW / HIGH ()1086.7 1868.8
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1999

Management Info :

Habil Khorakiwala - Chairman Murtaza Khorakiwala - Managing Director

Registered Office :

Address : D-4, M. I. D. C,Chikalthana, ,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006

Phone : 0240-6632222 / 6694444

Website : www.wockhardt.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
04May Wockhardt informs about press release
Pursuant to Regulation 30 of the Listing Regulations, Wockhardt has encl..
30Mar Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..
10Feb Wockhardt’s consolidated net profit ju
Wockhardt has reported results for third quarter ended December 31, 2025..
27Jan Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..
08Jan Wockhardt informs about compliances- c
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit16703170
Gross Profit 1670 3170
Operating Profit 21606540
Net Sales 516017390
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 17118.10 (2.24%)
M.Cap ( in Cr)
21955.79
Acutaas Chemicals (BSE)
 3030.45 (3.78%)
M.Cap ( in Cr)
24806.95
Hester Biosciences (BSE)
 1950.00 (3.43%)
M.Cap ( in Cr)
1618.13
Alivus Life Sciences (BSE)
 1109.95 (5.91%)
M.Cap ( in Cr)
13623.47
Bliss GVS Pharma (BSE)
 366.15 (15.29%)
M.Cap ( in Cr)
3863.94
Shareholding Pattern
PROMOTERS 49.08%
NON-INSTITUTION 32.84%
MUTUAL FUNDS/UTI 8.12%
FI/BANKS/INSURANCE 0.06%
GOVERNMENT 0.04%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX76565.7776.81 (0.10%)
NIFTY24078.1046.40 (0.19%)
Dow Jones 50579.70294.04 (0.58%)
Nasdaq 26343.9750.87 (0.19%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI